Výsledky vyhledávání - David I. Quinn
- Zobrazuji výsledky 1 - 20 z 79
- Přejít na další stránku
-
1
Targeted α-Particle Therapy of Bone Metastases in Prostate Cancer Autor Hossein Jadvar, David I. Quinn
Vydáno 2013Revisão -
2
Differentiating mTOR inhibitors in renal cell carcinoma Autor Sumanta K. Pal, David I. Quinn
Vydáno 2013Revisão -
3
-
4
-
5
-
6
-
7
-
8
-
9
Baseline <sup>18</sup>F-FDG PET/CT Parameters as Imaging Biomarkers of Overall Survival in Castrate-Resistant Metastatic Prostate Cancer Autor Hossein Jadvar, Bhushan Desai, Lingyun Ji, Peter S. Conti, Tanya B. Dorff, Susan Groshen, Jacek Pinski, David I. Quinn
Vydáno 2013Artigo -
10
Management Trends and Outcomes of Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: Evolution of the University of Southern California Experience over... Autor Anirban P. Mitra, Jie Cai, Gus Miranda, Sumeet Bhanvadia, David I. Quinn, Anne Schuckman, Hooman Djaladat, Siamak Daneshmand
Vydáno 2022Artigo -
11
A Phase I/<scp>IB</scp>, Open Label, Dose Finding Study to Evaluate Safety, Pharmacodynamics and Efficacy of Pembrolizumab in Combination With Vorinostat in Patients With Advanced... Autor Roberto Pili, David I. Quinn, Nabil Adra, Theodore F. Logan, Sean Colligan, Heather N. Burney, Noah M. Hahn
Vydáno 2025Artigo -
12
-
13
Prospective Evaluation of 18F-NaF and 18F-FDG PET/CT in Detection of Occult Metastatic Disease in Biochemical Recurrence of Prostate Cancer Autor Hossein Jadvar, Bhushan Desai, Lingyun Ji, Peter S. Conti, Tanya B. Dorff, Susan Groshen, Mitchell E. Gross, Jacek Pinski, David I. Quinn
Vydáno 2012Artigo -
14
-
15
-
16
Phase II Study of Aflibercept (VEGF-Trap) in Patients With Recurrent or Metastatic Urothelial Cancer, a California Cancer Consortium Trial Autor Przemyslaw Twardowski, Walter M. Stadler, Paul Frankel, Primo N. Lara, Christopher Ruel, Gurkamal Chatta, Elisabeth I. Heath, David I. Quinn, David R. Gandara
Vydáno 2010Artigo -
17
Robotic salvage retroperitoneal and pelvic lymph node dissection for ‘node‐only’ recurrent prostate cancer: technique and initial series Autor Andre Luis Abreu, Carlos Fay, Daniel Park, David I. Quinn, Tanya B. Dorff, John Carpten, Peter Kühn, Parkash S. Gill, Fábio Almeida, Inderbir S. Gill
Vydáno 2016Artigo -
18
A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium study Autor Primo N. Lara, Jeff Longmate, Christopher P. Evans, David I. Quinn, Przemyslaw Twardowski, Gurkamal Chatta, Edwin M. Posadas, Walter M. Stadler, David R. Gandara
Vydáno 2009Artigo -
19
-
20
Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis Autor Raj Satkunasivam, Andre E. Kim, Mihir Desai, Mike Nguyen, David I. Quinn, Leslie K. Ballas, Juan Pablo Lewinger, Mariana C. Stern, Ann S. Hamilton, Monish Aron, Inderbir S. Gill
Vydáno 2015Artigo
Vyhledávací nástroje:
Související témata
Medicine
Internal medicine
Cancer
Oncology
Prostate cancer
Urology
Chemotherapy
Biology
Immunotherapy
Cancer research
Gastroenterology
Renal cell carcinoma
Confidence interval
Surgery
Bladder cancer
Clinical endpoint
Hazard ratio
Pathology
Docetaxel
Clinical trial
Randomized controlled trial
Adverse effect
Pembrolizumab
Prostate
Biochemistry
Urothelial carcinoma
Alternative medicine
Genetics
Phases of clinical research
Androgen deprivation therapy